Approval · Notice of Compliance 10878 · 2009
BUSULFEX: Notice of Compliance 10878
Issued December 18, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10878
- Date
- December 18, 2009
- Company
- Otsuka Pharmaceutical Co LtdChiyoda-Ku Tokyo, Japan
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal of breast cancer and ovarian cancer from the Indications and Clinical Use and Clinical Trials sections of the Product Monograph
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUSULFEX | Not yet assigned | — |
Medicinal ingredients
- BUSULFAN 6 MG per ML